Title:
INDOLAMINE 2,3-DIOXYGENASE INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/141153
Kind Code:
A1
Abstract:
The present invention relates to a compound of formula I, a pharmaceutical composition comprising the compound of formula (I), a method for inhibiting indolamine 2,3-dioxygenase using the same and medical use thereof.
Inventors:
LI PAN (CN)
WEN QIAODONG (CN)
WANG JI (CN)
GAN QUAN (CN)
LU YANG (CN)
YANG DONGHUI (CN)
WEN QIAODONG (CN)
WANG JI (CN)
GAN QUAN (CN)
LU YANG (CN)
YANG DONGHUI (CN)
Application Number:
PCT/CN2019/071704
Publication Date:
July 25, 2019
Filing Date:
January 15, 2019
Export Citation:
Assignee:
ADLAI NORTYE BIOPHARMA CO LTD (CN)
International Classes:
C07D401/08; A61K31/4709; A61P31/12; A61P35/00; A61P37/02; A61P37/06; C07D413/08; C07D471/04
Domestic Patent References:
| WO2018039512A1 | 2018-03-01 |
Foreign References:
| CN106715417A | 2017-05-24 | |||
| CN1523989A | 2004-08-25 |
Other References:
VARIAM ULLAS JEANKUMAR ET AL.: "Engineering Another Class of Anti-Tubercular Lead: Hit to Lead Optimization of an Intriguing Class of Gyrase Atpase Inhibitors", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 122, 24 June 2016 (2016-06-24), pages 216 - 231, XP029705943, doi:10.1016/j.ejmech.2016.06.042
Attorney, Agent or Firm:
UNITALEN ATTORNEYS AT LAW (CN)
Download PDF:
Previous Patent: NOVEL COMPOSITE BIOLOGICAL AGENT BASED ON POROUS FRAME MATERIAL
Next Patent: PRODUCTION METHOD OF MICROBIAL BIOMASS
Next Patent: PRODUCTION METHOD OF MICROBIAL BIOMASS